Miller Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Miller Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.33M	Buy	38,962 +37	+0.1%	+$7.13K	0.73%	21
2025 Q4	$7.37M	Sell	38,925 -41,833	-52%	-$7.74M	0.72%	24
2025 Q3	$13.4M	Sell	80,758 -674	-0.8%	-$110K	1.34%	17
2025 Q2	$12.5M	Sell	81,432 -10,373	-11%	-$1.54M	1.31%	17
2025 Q1	$14.4M	Sell	91,805 -394	-0.4%	-$64K	1.6%	14
2024 Q4	$14.5M	Sell	92,199 -7,614	-8%	-$1.28M	1.58%	16
2024 Q3	$17.7M	Sell	99,813 -4,197	-4%	-$745K	1.84%	13
2024 Q2	$17.5M	Buy	104,010 +784	+0.8%	+$128K	2.09%	12
2024 Q1	$17.2M	Buy	103,226 +656	+0.6%	+$109K	2.19%	12
2023 Q4	$17M	Sell	102,570 -73,079	-42%	-$11.2M	2.41%	11
2023 Q3	$27.4M	Sell	175,649 -727	-0.4%	-$116K	4.3%	5
2023 Q2	$27.5M	Buy	176,376 +68,884	+64%	+$11M	4.2%	5
2023 Q1	$17.4M	Buy	107,492 +100,869	+1,523%	+$16.3M	2.88%	9
2022 Q4	$1.06M	Buy	6,623 +3,580	+118%	+$567K	0.18%	54
2022 Q3	$428K	Buy	3,043 +1,423	+88%	+$215K	0.09%	69
2022 Q2	$236K	Buy	+1,620	New	+$241K	0.05%	86

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Miller Investment Management's BBH Position: Q1 2026 in Review

Miller Investment Management increased its VanEck Biotech ETF (BBH) stake by 0.1% in Q1 2026, buying an estimated $7.13K and bringing the position to 38,962 shares worth $7.33M. The position accounts for 0.73% of the portfolio, ranked #21.

Miller Investment Management first reported a position in BBH in Q2 2022 and has held it in 16 quarters since. The position peaked at $27.5M in Q2 2023. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Miller Investment Management held 38,962 shares of VanEck Biotech ETF worth $7.33M as of Q1 2026.
Miller Investment Management bought 37 VanEck Biotech ETF shares in Q1 2026, an estimated $7.13K.
VanEck Biotech ETF made up 0.73% of Miller Investment Management's portfolio in Q1 2026, its #21 holding.
Miller Investment Management first reported a position in VanEck Biotech ETF in Q2 2022 and has held it in 16 quarters since.
Miller Investment Management's VanEck Biotech ETF position peaked at $27.5M in Q2 2023.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.